Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

TALK vs DOCS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
TALK
Talkspace, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$868M
5Y Perf.-37.7%
DOCS
Doximity, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$5.24B
5Y Perf.-55.3%

TALK vs DOCS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
TALK logoTALK
DOCS logoDOCS
IndustryMedical - Care FacilitiesMedical - Healthcare Information Services
Market Cap$868M$5.24B
Revenue (TTM)$229M$638M
Net Income (TTM)$8M$239M
Gross Margin43.0%89.7%
Operating Margin1.4%37.4%
Forward P/E38.2x16.8x
Total Debt$0.00$12M
Cash & Equiv.$37M$210M

TALK vs DOCSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

TALK
DOCS
StockJun 21May 26Return
Talkspace, Inc. (TALK)10062.3-37.7%
Doximity, Inc. (DOCS)10044.7-55.3%

Price return only. Dividends and distributions are not included.

Quick Verdict: TALK vs DOCS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: TALK and DOCS are tied at the top with 3 categories each — the right choice depends on your priorities. Doximity, Inc. is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
TALK
Talkspace, Inc.
The Income Pick

TALK has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.

  • beta 0.86
  • Rev growth 22.0%, EPS growth 6.5%, 3Y rev CAGR 24.2%
  • -48.7% 10Y total return vs DOCS's -50.9%
Best for: income & stability and growth exposure
DOCS
Doximity, Inc.
The Value Play

DOCS is the clearest fit if your priority is value and quality.

  • Lower P/E (16.8x vs 38.2x)
  • 37.5% margin vs TALK's 3.4%
  • 20.7% ROA vs TALK's 5.9%, ROIC 20.0% vs 3.9%
Best for: value and quality
See the full category breakdown
CategoryWinnerWhy
GrowthTALK logoTALK22.0% revenue growth vs DOCS's 20.0%
ValueDOCS logoDOCSLower P/E (16.8x vs 38.2x)
Quality / MarginsDOCS logoDOCS37.5% margin vs TALK's 3.4%
Stability / SafetyTALK logoTALKBeta 0.86 vs DOCS's 1.03
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)TALK logoTALK+70.4% vs DOCS's -55.4%
Efficiency (ROA)DOCS logoDOCS20.7% ROA vs TALK's 5.9%, ROIC 20.0% vs 3.9%

TALK vs DOCS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

TALKTalkspace, Inc.

Segment breakdown not available.

DOCSDoximity, Inc.
FY 2025
Subscription
95.3%$544M
Service, Other
4.7%$27M

TALK vs DOCS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDOCSLAGGINGTALK

Income & Cash Flow (Last 12 Months)

DOCS leads this category, winning 4 of 5 comparable metrics.

DOCS is the larger business by revenue, generating $638M annually — 2.8x TALK's $229M. DOCS is the more profitable business, keeping 37.5% of every revenue dollar as net income compared to TALK's 3.4%. On growth, TALK holds the edge at +29.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricTALK logoTALKTalkspace, Inc.DOCS logoDOCSDoximity, Inc.
RevenueTrailing 12 months$229M$638M
EBITDAEarnings before interest/tax$7M$250M
Net IncomeAfter-tax profit$8M$239M
Free Cash FlowCash after capex-$2M$314M
Gross MarginGross profit ÷ Revenue+43.0%+89.7%
Operating MarginEBIT ÷ Revenue+1.4%+37.4%
Net MarginNet income ÷ Revenue+3.4%+37.5%
FCF MarginFCF ÷ Revenue-0.9%+49.2%
Rev. Growth (YoY)Latest quarter vs prior year+29.3%+9.8%
EPS Growth (YoY)Latest quarter vs prior year-16.2%
DOCS leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

DOCS leads this category, winning 4 of 5 comparable metrics.

At 23.5x trailing earnings, DOCS trades at a 82% valuation discount to TALK's 129.5x P/E. On an enterprise value basis, DOCS's 21.1x EV/EBITDA is more attractive than TALK's 137.8x.

MetricTALK logoTALKTalkspace, Inc.DOCS logoDOCSDoximity, Inc.
Market CapShares × price$868M$5.2B
Enterprise ValueMkt cap + debt − cash$830M$5.0B
Trailing P/EPrice ÷ TTM EPS129.50x23.45x
Forward P/EPrice ÷ next-FY EPS est.38.20x16.83x
PEG RatioP/E ÷ EPS growth rate0.30x
EV / EBITDAEnterprise value multiple137.77x21.14x
Price / SalesMarket cap ÷ Revenue3.79x9.18x
Price / BookPrice ÷ Book value/share7.69x4.84x
Price / FCFMarket cap ÷ FCF19.64x
DOCS leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

DOCS leads this category, winning 6 of 7 comparable metrics.

DOCS delivers a 24.4% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $7 for TALK. On the Piotroski fundamental quality scale (0–9), DOCS scores 9/9 vs TALK's 6/9, reflecting strong financial health.

MetricTALK logoTALKTalkspace, Inc.DOCS logoDOCSDoximity, Inc.
ROE (TTM)Return on equity+6.9%+24.4%
ROA (TTM)Return on assets+5.9%+20.7%
ROICReturn on invested capital+3.9%+20.0%
ROCEReturn on capital employed+2.7%+22.3%
Piotroski ScoreFundamental quality 0–969
Debt / EquityFinancial leverage0.01x
Net DebtTotal debt minus cash-$37M-$197M
Cash & Equiv.Liquid assets$37M$210M
Total DebtShort + long-term debt$0$12M
Interest CoverageEBIT ÷ Interest expense
DOCS leads this category, winning 6 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

TALK leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in TALK five years ago would be worth $5,232 today (with dividends reinvested), compared to $4,911 for DOCS. Over the past 12 months, TALK leads with a +70.4% total return vs DOCS's -55.4%. The 3-year compound annual growth rate (CAGR) favors TALK at 80.7% vs DOCS's -8.8% — a key indicator of consistent wealth creation.

MetricTALK logoTALKTalkspace, Inc.DOCS logoDOCSDoximity, Inc.
YTD ReturnYear-to-date+47.6%-39.9%
1-Year ReturnPast 12 months+70.4%-55.4%
3-Year ReturnCumulative with dividends+490.0%-24.2%
5-Year ReturnCumulative with dividends-47.7%-50.9%
10-Year ReturnCumulative with dividends-48.7%-50.9%
CAGR (3Y)Annualised 3-year return+80.7%-8.8%
TALK leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

TALK leads this category, winning 2 of 2 comparable metrics.

TALK is the less volatile stock with a 0.86 beta — it tends to amplify market swings less than DOCS's 1.03 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TALK currently trades 99.6% from its 52-week high vs DOCS's 34.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricTALK logoTALKTalkspace, Inc.DOCS logoDOCSDoximity, Inc.
Beta (5Y)Sensitivity to S&P 5000.86x1.03x
52-Week HighHighest price in past year$5.20$76.51
52-Week LowLowest price in past year$2.22$20.55
% of 52W HighCurrent price vs 52-week peak+99.6%+34.0%
RSI (14)Momentum oscillator 0–10062.760.1
Avg Volume (50D)Average daily shares traded4.5M2.7M
TALK leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates TALK as "Hold" and DOCS as "Buy". Consensus price targets imply 64.4% upside for DOCS (target: $43) vs 1.4% for TALK (target: $5).

MetricTALK logoTALKTalkspace, Inc.DOCS logoDOCSDoximity, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$5.25$42.79
# AnalystsCovering analysts1022
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+2.0%+2.3%
Insufficient data to determine a leader in this category.
Key Takeaway

DOCS leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). TALK leads in 2 (Total Returns, Risk & Volatility).

Best OverallDoximity, Inc. (DOCS)Leads 3 of 6 categories
Loading custom metrics...

TALK vs DOCS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is TALK or DOCS a better buy right now?

For growth investors, Talkspace, Inc.

(TALK) is the stronger pick with 22. 0% revenue growth year-over-year, versus 20. 0% for Doximity, Inc. (DOCS). Doximity, Inc. (DOCS) offers the better valuation at 23. 5x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate Doximity, Inc. (DOCS) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — TALK or DOCS?

On trailing P/E, Doximity, Inc.

(DOCS) is the cheapest at 23. 5x versus Talkspace, Inc. at 129. 5x. On forward P/E, Doximity, Inc. is actually cheaper at 16. 8x.

03

Which is the better long-term investment — TALK or DOCS?

Over the past 5 years, Talkspace, Inc.

(TALK) delivered a total return of -47. 7%, compared to -50. 9% for Doximity, Inc. (DOCS). Over 10 years, the gap is even starker: TALK returned -48. 7% versus DOCS's -50. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — TALK or DOCS?

By beta (market sensitivity over 5 years), Talkspace, Inc.

(TALK) is the lower-risk stock at 0. 86β versus Doximity, Inc. 's 1. 03β — meaning DOCS is approximately 20% more volatile than TALK relative to the S&P 500.

05

Which is growing faster — TALK or DOCS?

By revenue growth (latest reported year), Talkspace, Inc.

(TALK) is pulling ahead at 22. 0% versus 20. 0% for Doximity, Inc. (DOCS). Over a 3-year CAGR, TALK leads at 24. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — TALK or DOCS?

Doximity, Inc.

(DOCS) is the more profitable company, earning 39. 1% net margin versus 3. 4% for Talkspace, Inc. — meaning it keeps 39. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOCS leads at 39. 9% versus 1. 4% for TALK. At the gross margin level — before operating expenses — DOCS leads at 90. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is TALK or DOCS more undervalued right now?

On forward earnings alone, Doximity, Inc.

(DOCS) trades at 16. 8x forward P/E versus 38. 2x for Talkspace, Inc. — 21. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DOCS: 64. 4% to $42. 79.

08

Which pays a better dividend — TALK or DOCS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is TALK or DOCS better for a retirement portfolio?

For long-horizon retirement investors, Talkspace, Inc.

(TALK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 86)). Both have compounded well over 10 years (TALK: -48. 7%, DOCS: -50. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between TALK and DOCS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

TALK

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 25%
Run This Screen
Stocks Like

DOCS

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 22%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform TALK and DOCS on the metrics below

Revenue Growth>
%
(TALK: 29.3% · DOCS: 9.8%)
Net Margin>
%
(TALK: 3.4% · DOCS: 37.5%)
P/E Ratio<
x
(TALK: 129.5x · DOCS: 23.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.